In the Media

November 1, 2018

UBC’s Dr. Yadav Talks about Producing Bio-identical Cannabinoids in the Lab using Biosynthesis

In this video, Dr. Vikramaditya Yadav of the University of British Columbia talks about using a unique biosynthesis platform to productively produce bioidentical, high purity, high grade cannabinoids. InMed collaborates with Dr. Yadav’s laboratory in developing a proprietary biosynthesis platform.

Source: BTV

Share this post

Latest Media News

Cannabinol 101: The Science of Cannabinol (CBN)

Cannabinol, or CBN for short, is one of the more than 100 rare cannabinoids found in the Cannabis plant. CBN is found in aged Cannabis

June 8, 2020

InMed’s cannabinol (CBN) formulation for glaucoma – Executive Interview with CEO Eric A. Adams

In this video, InMed Pharmaceuticals CEO Eric A. Adams speaks about the company’s ocular disease program. INM-088 is a cannabinol (CBN) formulation showing potential to

May 27, 2020

InMed’s therapeutic development of cannabinol and update on programs – Executive Interview with CEO Eric A. Adams

In this video, InMed Pharmaceuticals’ CEO Eric A. Adams speaks about the company’s therapeutic development of cannabinol (CBN), a rare cannabinoid showing potential to treat

May 11, 2020